NCT06946095View on ClinicalTrials.gov

Efficacy and Safety of Xinyue Capsule in the Treatment of Heart Failure With Preserved Ejection Fraction

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

246

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions

Heart Failure

Interventions

DRUG

Chinese patent medicine

This study aims to investigate whether the addition of Xinyue Capsule to conventional Western medical therapy significantly improves cardiac function and reduces the level of heart failure biomarker NT-proBNP in patients with Heart Failure with Preserved Ejection Fraction (HFpEF).

All Listed Sponsors

lead

Beijing Anzhen Hospital

OTHER